Grifols Therapeutics Overview
Company Headquarters: Spain
Founded: 1909
Workforce: ~ 4,763
Company Working:
Grifols Therapeutics, Inc. operates as a biotherapeutic and biotechnology company. The Company discovers, develops, and produces critical care treatment products for the people with life-threatening disorders. Grifols Therapeutics serves patients, hospitals, pharmacies, and healthcare professionals worldwide. Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing, and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing, and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies. Grifols' plasma fractionation capacity is 3.6 million liters of plasma a year and is carried out in the company's two plants located in Parets del Valles (Barcelona) and Los Angeles.



